This document is a publication of a new patent application filed with the USPTO, specifically application US20260083813A1. The application describes methods and compositions utilizing naturally occurring plants, such as Dichrostachys glomerata or Cissus quadrangularis, to reduce Dipeptidyl Peptidase-4 (DPP-4) activity or levels in mammals. It also claims benefits such as increasing GLP-1 levels, reducing visceral fat, food intake, blood lipids, total cholesterol, and total glucose.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in the pharmaceutical and dietary supplement industries related to these plant-based compounds for therapeutic or health-related purposes. Companies in the pharmaceutical and food manufacturing sectors may wish to monitor the progress of this patent application and related research.